CPT 88381Laboratory

Microdissection manual

CPT 88381 covers the manual microdissection of tissue samples under microscopic visualization to isolate specific cells or tissue areas for further molecular or genetic testing. This highly specialized lab technique separates target cells from surrounding tissue to ensure accurate downstream analysis.

Showing rates for

National Average

Base Medicare rate

$188.58

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

0.53

PE RVU (NF)

5.25

MP RVU

0.05

Total RVU

5.83

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Document the exact time spent on microdissection and number of cells/areas isolated, as the work RVU of 0.53 reflects significant manual effort
Impact: Detailed time documentation supports medical necessity and can prevent denials worth the full $188.58 reimbursement
Always link 88381 to the appropriate downstream molecular test code (e.g., 81235, 81445) to establish medical necessity for the microdissection
Impact: Failure to demonstrate necessity for molecular testing can result in denial of the $188.58 charge
Bill 88381 only once per specimen regardless of how many different areas are microdissected from that single specimen
Impact: Avoid upcoding denials; multiple areas from one specimen do not qualify for multiple units
Ensure documentation specifies manual microdissection versus laser capture microdissection (which has different codes)
Impact: Coding the wrong dissection method can lead to denials or requests for refund of $188.58
Verify that the tumor cellularity percentage is documented before and after microdissection to justify the procedure
Impact: Payers increasingly require proof that microdissection was necessary (typically when initial tumor content <50%)
For Medicare patients, confirm the molecular test being performed is on an FDA-approved or LCD-covered panel
Impact: If downstream test is not covered, the preparatory microdissection (88381) may also be denied

Common denials

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88381?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 88381 in 2025?

The 2025 Medicare national average reimbursement rate for CPT 88381 is $188.58 for both facility and non-facility settings, based on a total RVU of 5.83 and conversion factor of 32.3465.

Can CPT 88381 be billed with molecular pathology codes?

Yes, CPT 88381 is separately reportable and commonly billed with molecular pathology codes such as 81235, 81445, or other genomic sequencing procedures. The microdissection must be documented as medically necessary to enrich tumor cellularity for accurate molecular testing.

How many times can I bill 88381 for one patient specimen?

CPT 88381 should be billed only once per specimen regardless of how many different areas are microdissected from that specimen. If truly separate specimens from different anatomic sites are microdissected, each can be billed separately with appropriate documentation.

What is the difference between CPT 88381 and laser capture microdissection?

CPT 88381 specifically describes manual microdissection using physical manipulation under microscopic visualization. Laser capture microdissection (LCM) uses laser technology and may be reported with different codes depending on the specific technique and payer guidelines.

What documentation is required to justify billing CPT 88381?

Required documentation includes pre-dissection tumor cellularity assessment, detailed description of manual microdissection method and areas targeted, time spent, post-dissection purity assessment, link to the downstream molecular test requiring enriched tissue, and pathologist supervision verification.

Do private payers reimburse CPT 88381 the same as Medicare?

Private payer reimbursement varies significantly and may range from 100-200% of Medicare rates. Some payers have specific policies requiring pre-authorization for microdissection or limiting coverage to certain molecular tests. Always verify coverage and rates with individual payers.

Is CPT 88381 subject to CLIA regulations and what complexity level?

Yes, CPT 88381 is subject to CLIA regulations and is classified as high-complexity testing. The laboratory must have a CLIA certificate for high-complexity testing, and personnel must meet qualifications including specialized training in microdissection techniques under pathologist supervision.